X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-12 | IRWD | Shetzline Michael | CMO,SVP,Head-Res, Drug | S - Sale+OE | $15.24 | -38,618 | 394,911 | -9% | -$588,538 | |||||
2023-05-22 | IRWD | Shetzline Michael | CMO,SVP,Head-Res, Drug | S - Sale | $10.12 | -10,324 | 321,131 | -3% | -$104,479 | ||||||
| M | 2023-02-27 | IRWD | Shetzline Michael | CMO,SVP,Head-Res, Drug | S - Sale | $11.36 | -19,322 | 261,586 | -7% | -$219,479 | |||||
2022-05-23 | IRWD | Shetzline Michael | CMO,SVP,Head-Res, Drug | S - Sale | $11.50 | -10,583 | 266,245 | -4% | -$121,705 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |